Senti Biosciences's total assets for Q1 2026 were $38.24M, a decrease of -25.34% from the previous quarter. SNTI total liabilities were $35.68M for the fiscal quarter, a -21.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.